Informações:
Falhas:
ID
39865
Descrição
ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA; ODM derived from: https://clinicaltrials.gov/show/NCT01730612
Link
https://clinicaltrials.gov/show/NCT01730612
Palavras-chave
Versões (1)
- 25/02/2020 25/02/2020 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
25 de fevereiro de 2020
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility HER2 Negative Breast Carcinoma Expressing CEA NCT01730612
Eligibility HER2 Negative Breast Carcinoma Expressing CEA NCT01730612
- StudyEvent: Eligibility
Similar models
Eligibility HER2 Negative Breast Carcinoma Expressing CEA NCT01730612
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
HER2-positive carcinoma of breast metastatic FISH | Status post Treatment
Item
breast carcinoma, her2 + (dako) and her2 + (fish) metastatic at least after treatment with current consensus
boolean
C1960398 (UMLS CUI [1,1])
C1522484 (UMLS CUI [1,2])
C0162789 (UMLS CUI [1,3])
C0231290 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1522484 (UMLS CUI [1,2])
C0162789 (UMLS CUI [1,3])
C0231290 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
Age
Item
≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods
Item
negative pregnancy test for women of childbearing age. women of childbearing age should take effective contraception continuously for 3 months.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Karnofsky Performance Status
Item
karnofsky ≥ 70 or ecog 0-1
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of at least 6 months
boolean
C0023671 (UMLS CUI [1])
ACE Tumor Immunohistochemistry | Plasma CEA measurement
Item
ace of the tumor by immunohistochemistry or positive plasma cea ≥ 10 ng / ml
boolean
C0022709 (UMLS CUI [1,1])
C0027651 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,3])
C0032105 (UMLS CUI [2,1])
C0201933 (UMLS CUI [2,2])
C0027651 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,3])
C0032105 (UMLS CUI [2,1])
C0201933 (UMLS CUI [2,2])
Measurable lesion Quantity CT
Item
at least one measurable lesion on ct
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
Creatinine measurement, serum
Item
creatinine < 2.5
boolean
C0201976 (UMLS CUI [1])
Informed Consent
Item
informed consent signed
boolean
C0021430 (UMLS CUI [1])
Social insurance
Item
social insurance
boolean
C0037435 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Illness Serious | Comorbidity Risk Assessed
Item
serious illness or co-morbidity risk assessed
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C1516048 (UMLS CUI [2,3])
C0205404 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C1516048 (UMLS CUI [2,3])
Malignant Neoplasms | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix
Item
history of cancer within 5 years except skin cancer other than melanoma or carcinoma in situ of the cervix
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
Anti-Antibodies | Patients Antibodies Previous
Item
presence of anti-antibodies in patients who have previously received antibodies
boolean
C1624602 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C0003241 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
C0030705 (UMLS CUI [2,1])
C0003241 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
Hypersensitivity Antibodies | Protein allergy
Item
known hypersensitivity to antibodies or proteins
boolean
C0020517 (UMLS CUI [1,1])
C0003241 (UMLS CUI [1,2])
C1112677 (UMLS CUI [2])
C0003241 (UMLS CUI [1,2])
C1112677 (UMLS CUI [2])
Intellectual Disability | Informed Consent Unable
Item
intellectual disability to sign the informed consent
boolean
C3714756 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Diabetes Mellitus
Item
diabetes
boolean
C0011849 (UMLS CUI [1])
Protection of patient Legal
Item
persons protected by law
boolean
C0412786 (UMLS CUI [1,1])
C1301860 (UMLS CUI [1,2])
C1301860 (UMLS CUI [1,2])